以治愈为目的的脑动静脉畸形栓塞治疗:一项系统综述
该系统综述纳入15项研究、597例患者和598个脑动静脉畸形,评估以治愈为目的的栓塞治疗的病变特征、技术因素及血管造影和临床结局。栓塞后即刻完全闭塞在完成治疗的动静脉畸形中为58.3%,在全体患者队列中为45.8%;总体临床并发症率为24.1%,最常见为出血(9.7%),手术相关死亡率为1.5%。作者认为治愈性栓塞可作为部分动静脉畸形的选择,但并发症率高于以辅助栓塞为目标的研究,应视为非预期获益而非治疗目标。
要点
- 栓塞后即刻完全闭塞在完成治疗的动静脉畸形中为58.3%,在全体队列中为45.8%。
- 总体临床并发症率为24.1%,最常见并发症为出血,发生于9.7%的患者。
- 手术相关死亡率为1.5%,并发症率高于以辅助栓塞为目标的研究。
核心结论
- 以治愈为目的的血管内栓塞可作为部分动静脉畸形的选择,但报告的并发症率似乎高于以辅助栓塞为目标的研究。
- 鉴于初次栓塞策略相关的高并发症率,应在多学科团队中讨论该治疗策略的风险与获益。
- 动静脉畸形的治愈性栓塞应被视为该治疗的非预期获益而非目标。
研究设计与样本
- 系统综述,检索Ovid MEDLINE、Ovid Embase和PubMed数据库中有关以治愈为目的的血管内栓塞治疗动静脉畸形的研究。
- 纳入15项研究,共597例患者和598个接受治愈意图栓塞治疗的动静脉畸形。
- 主要结局为栓塞后即刻和随访时的血管造影闭塞,次要结局为并发症率,采用描述性统计计算率和均值。
主要发现
- 34%的动静脉畸形为Spetzler-Martin III级。
- 栓塞后即刻完全闭塞在完成治疗的动静脉畸形中为58.3%,在全体患者队列中为45.8%。
- 总体临床并发症率为24.1%,最常见并发症为出血,发生于9.7%的患者。
- 手术相关死亡率为1.5%。
关键数值与推荐
- 以治愈为目的的栓塞治疗中,完成治疗的动静脉畸形即刻完全闭塞率为58.3%。
- 全体患者队列的动静脉畸形即刻完全闭塞率为45.8%。
- 总体临床并发症率为24.1%,出血发生率为9.7%,手术相关死亡率为1.5%。
临床怎么用
- 作者认为,以治愈为目的的血管内栓塞可作为部分动静脉畸形的选择。
- 作者认为,鉴于初次栓塞策略相关的高并发症率,应在多学科团队中讨论该治疗策略的风险与获益。
- 作者认为,动静脉畸形的治愈性栓塞应被视为该治疗的非预期获益而非目标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular embolization has been established as an adjuvant treatment strategy for brain arteriovenous malformations (AVMs). A growing body of literature has discussed curative embolization for select lesions. The transition of endovascular embolization from an adjunctive to a definitive treatment modality remains controversial. Here, the authors reviewed the literature to assess the lesional characteristics, technical factors, and angiographic and clinical outcomes of endovascular embolization of AVMs with intent to cure. METHODS: Electronic databases-Ovid MEDLINE, Ovid Embase, and PubMed-were searched for studies in which there was evidence of AVMs treated using endovascular embolization with intent to cure. The primary outcomes of interest were angiographic obliteration immediately postembolization and at follow-up. The secondary outcomes of interest were complication rates. Descriptive statistics were used to calculate rates and means. RESULTS: Fifteen studies with 597 patients and 598 AVMs treated with intent-to-cure embolization were included in this analysis. Thirty-four percent of AVMs were Spetzler-Martin grade III. Complete obliteration immediately postembolization was reported in 58.3% of AVMs that had complete treatment and in 45.8% of AVMs in the entire patient cohort. The overall clinical complication rate was 24.1%. The most common complication was hemorrhage, occurring in 9.7% of patients. Procedure-related mortality was 1.5%. CONCLUSIONS: While endovascular embolization with intent to cure can be an option for select AVMs, the reported complication rates appear to be increased compared with those in studies in which adjunctive embolization was the goal. Given the high complication rate related to a primary embolization approach, the risks and benefits of such a treatment strategy should be discussed among a multidisciplinary team. Curative embolization of AVMs should be considered an unanticipated benefit of such therapy rather than a goal.
引用
- Wu EM, El Ahmadieh TY, McDougall CM, et al. Embolization of brain arteriovenous malformations with intent to cure: a systematic review. J Neurosurg. 2019. PMID: 30717053. doi:10.3171/2018.10.JNS181791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。